Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Memantine HCl

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 548Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amneal Gets FDA Nod For Memantine/Donepezil & Everolimus
    Amneal Gets FDA Nod For Memantine/Donepezil & Everolimus

    23 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250123740756/en

    BUSINESSWIRE
    23 Jan 2025
    Share Share
    Xiamen LP Pharm’s Generic Memantine:Donepezil HCl Receives Tentative Approval In U.S
    Xiamen LP Pharm’s Generic Memantine:Donepezil HCl Receives Tentative Approval In U.S

    02 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216901

    FDA
    02 May 2024
    Share Share
    Xiamen's Generic Memantine, Donepezil Receives Approval in the U.S.
    Xiamen's Generic Memantine, Donepezil Receives Approval in the U.S.

    07 Apr 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216901

    FDA
    07 Apr 2023
    Share Share
    AbbVie agrees to pay $54.4 mln in antitrust case over Alzheimer's drug
    AbbVie agrees to pay $54.4 mln in antitrust case over Alzheimer's drug

    15 Nov 2022

    // REUTERS

    https://www.reuters.com/legal/litigation/abbvie-agrees-pay-544-mln-antitrust-case-over-alzheimers-drug-2022-11-14/?rpc=401&

    REUTERS
    15 Nov 2022
    Share Share
    Xiamen's Generic Memantine Hydrochloride Receives Approval in the U.S.
    Xiamen's Generic Memantine Hydrochloride Receives Approval in the U.S.

    11 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213985

    FDA
    11 Oct 2022
    Share Share
    Hetero's Generic Memantine Hydrochloride Receives Approval in the U.S.
    Hetero's Generic Memantine Hydrochloride Receives Approval in the U.S.

    26 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204389

    FDA
    26 Sep 2022
    Share Share